Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 6Neoplasms 4Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Radiation Injuries 2Osteosarcoma 2Melanoma 2Lung Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Cognitive Dysfunction 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Thymus Neoplasms 1Thoracic Neoplasms 1Testicular Neoplasms 1Substance-Related Disorders 1Stomach Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Kaposi 1

Interventions

Drug Therapy 2Tyrosine Kinase Inhibitors 1Trastuzumab 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Semen Analysis 1Registries 1Radiotherapy 1Patient Reported Outcome Measures 1Lenalidomide 1Interviews as Topic 1Data Collection 1Cisplatin 1Choledochostomy 1Bleomycin 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms, Second Primary × Patient Reported Outcome Measures × Clear all
NCT04151342 2025-12-03

CARMA-BROS

University Health Network, Toronto

Recruiting
5,500 enrolled

Congenital Abnormalities, Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡